Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects

BACKGROUND: Immunotherapy in microsatellite stable colorectal or pancreatic cancer has not shown promising results. It has been hypothesized that targeting immunosuppressive molecules like SDF1-alpha/CXCL12 could contribute to immunotherapy and animal models showed promising results on T cell activa...

Descripción completa

Detalles Bibliográficos
Autores principales: Suarez-Carmona, Meggy, Williams, Anja, Schreiber, Jutta, Hohmann, Nicolas, Pruefer, Ulrike, Krauss, Jürgen, Jäger, Dirk, Frömming, Anna, Beyer, Diana, Eulberg, Dirk, Jungelius, Jarf Ulf, Baumann, Matthias, Mangasarian, Aram, Halama, Niels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491418/
https://www.ncbi.nlm.nih.gov/pubmed/34607895
http://dx.doi.org/10.1136/jitc-2021-002505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491418/
https://www.ncbi.nlm.nih.gov/pubmed/34607895
http://dx.doi.org/10.1136/jitc-2021-002505

Ejemplares similares